Cleerly, a cardiovascular imaging startup, uses AI to detect early-stage coronary artery disease from CT scans. A recent podcast episode highlighted Cleerly's $106 million Series C extension funding round, led by Insight Partners, which will fuel further growth and clinical trials. The company's technology offers a less invasive alternative to traditional methods like stress tests and angiograms, and has already gained Medicare coverage. Despite competition, Cleerly's rapid growth and potential for widespread screening make it a promising player in the heart health market.

The podcast, "Startup News," provides news and updates on startups in the technology sector.